Bao, H., Yu, K., An, F., & Wu, X. (2025). Tofacitinib as a promising treatment for refractory erythroderma-like Hailey–Hailey disease. Journal of Dermatological Treatment, 36(1), 1. https://doi.org/10.1080/09546634.2025.2493936
Chicago Style (17th ed.) CitationBao, Huaye, Keyi Yu, Feilong An, and Xin-gang Wu. "Tofacitinib as a Promising Treatment for Refractory Erythroderma-like Hailey–Hailey Disease." Journal of Dermatological Treatment 36, no. 1 (2025): 1. https://doi.org/10.1080/09546634.2025.2493936.
MLA (9th ed.) CitationBao, Huaye, et al. "Tofacitinib as a Promising Treatment for Refractory Erythroderma-like Hailey–Hailey Disease." Journal of Dermatological Treatment, vol. 36, no. 1, 2025, p. 1, https://doi.org/10.1080/09546634.2025.2493936.